|
Wednesday, November 14, 2018
Print Current Session:
 |
|
|
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs), OTHER DEVICES FOR TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS, RANDOMIZED TRIALS (RCTs) AND BTK TREATMENTS
|
|
| SESSION 26 SCHEDULE | |
| 10:16 AM - 10:21 AM | Impact And Significance Of Downstream Embolization And Restenosis With Different DCBs |
|
Presenter(s):Aloke Finn, MD / Renu Virmani, MD |
|
| View Slides in PDF | |
| 10:22 AM - 10:27 AM | DCBs Are Changing The Landscape And Algorithm For Treating Long Complex SFA/Pop Lesions And Minimizing The Need For Stents: Advantages Of Sirolimus vs. Paclitaxel Coatings |
|
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:28 AM - 10:33 AM | Update On In.Pact SFA I And II RCTs Show Benefit Of In.Pact (Medtronic) DCBs Persisting And Increasing Over POBA At 4 years With Fem/Pop Lesions |
|
Presenter(s):John R. Laird, MD / Peter A. Schneider, MD / Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:34 AM - 10:39 AM | Update On Persistent Benefit Of Lutonix DCB (Bard/BD) For Fempop Lesions As Shown By A RCT vs. Plain Balloon Angioplasty (POBA): Long Lesions (>14 cm) Were Included |
|
Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:40 AM - 10:45 AM | COMPARE Pilot RCT: 1 Year Results Of A Randomized Comparison Of RANGER DCB vs. IN.PACT DCB In Complex SFA Lesions |
|
Presenter(s):Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:46 AM - 10:51 AM | Update On ILLUMINATE RCTs With Stellarex DCBs (Spectranetics/Philips): 2- And 3-Year Results For SFA/Pop Lesions And ISR Are Equal To Other DCBs: Advantages Over Other DCBs |
|
Presenter(s):Sean P. Lyden, MD / Timothy M. Sullivan, MD / Thomas Zeller, MD / Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:52 AM - 10:57 AM | Lessons Learned From The In.Pact DCB GLOBAL Registry - Chronic Total Occlusion (CTO) Cohort: How To Make DCBs Work Best With CTOs |
|
Presenter(s):Marianne Brodmann, MD / Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:58 AM - 11:03 AM | In.Pact DCBs Have Equal Benefits When Treating Long SFA/Pop Lesions As When Treating Shorter Lesions |
|
Presenter(s):Antonio Micari, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:04 AM - 11:11 AM | Panel Discussion |
| Moderator(s): Sean P. Lyden, MD / Giancarlo Biamino, MD, PhD | |
| 11:11 AM - 11:16 AM | What Is The Long-Term Durability Of The Benefits Of The Different DCBs: What Is The Value Of Spot Stenting Of Residual Stenoses With DCBs |
|
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:17 AM - 11:22 AM | Present Role For DCBs And DESs For SFA Lesions: Updated Treatment Algorithm And How To Deal With Severe Calcification |
|
Presenter(s):Fabrizio Fanelli, MD, EBIR Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:23 AM - 11:28 AM | Update On Evaluation Of DCBs: When Are They Worthwhile And Advantages Of Different DCBs |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| DCBS FOR BTK LESIONS | |
| 11:29 AM - 11:34 AM | Value Of DCBs In BTK And Crural Arteries: Reasons For Past Failures: New Technology, New Results And Promising Future Prospects |
|
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:35 AM - 11:40 AM | Value Of Stellarex DCBs (Spectranetics/Philips) In BTK And Infrapopliteal Artery Lesions |
|
Presenter(s):Gunnar Tepe, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:41 AM - 11:46 AM | > 1-Year Safety And Effectiveness Results Of Lutonix DCBs (Bard/BD) For Treating BTK And Crural Artery Lesions: Late Breaking Update And 6-Month Results Of Lutonix Below-The-Knee Global DCB IDE RCT Study |
|
Presenter(s):Patrick J. Geraghty, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:47 AM - 11:52 AM | Update On Value Of The Chocolate Touch (Restrained) DCB (QT Vascular And TriReme Medical): What Makes It Different And 2-Year Results From The ENDURE Trial |
|
Presenter(s):Gunnar Tepe, MD / D. Christopher Metzger, MD / Andrew Holden, MBChB / Wei Guo, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:53 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break - 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 26 | |
| previous | next |